We are happy to welcome you for the official website of 3rd International Conference on Neuro-Oncology and Brain Tumour during September 14-15, 2018 in Singapore with the theme of "Innovative Techniques and Advancements in Neuro-Oncology" which covers wide range of critically important sessions. It’s a platform to bring all the neurooncologists and Neuroscientists together to share their experiences it’s the amalgam of scientific research as well as innovative ideas.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint provider ship of Peer Point Medical Education Institute and Conference Series, LLC. Peer Point Medical Education Institute is accredited by the ACCME to provide continuing medical education for physicians.
Overview of Neuro-oncology and Brain tumour:
An important area of clinical Neuro-Oncology and Brain Tumour that is increasingly relevant as survivorship increases and as patients experience potential morbidities associated with new therapies. Neuro-Oncology is the study of Brain and Spinal cord neoplasms, many of which are (at least eventually) very dangerous and life-threatening (Astrocytoma, Glioma, Glioblastoma multiforme, Ependymoma, Pontine Glioma, and Brain stem tumors are among the many examples of these). Among the Malignant Brain cancers, Gliomas of the brainstem and pons, Glioblastoma multiform, and high-grade (highly anaplastic) Astrocytoma are among the worst.
Geographically market is segmented into Europe, North America, Latin America, Asia pacific, and Middle East and Africa. According to market study, Market Value for Neuro Oncology (i.e. on Brain Cancer and CNS Tumors) will be more than double to $ 623 Million by 2020. A major part of research is going on the top Universities on across the globe. Many companies are associated with various diagnostic instruments and other therapeutics. Besides this various societies and research labs are also associated in this research field.
Who Should Attend?
- Head of Department
- Industrial Researchers
- Radiation Oncologists
- Rehabilitation Specialists
- Neuroscience Researchers and Students from academia in the research of Neuro-oncology, Neurooncology Associations, Brain tumour societies
- Academia: 65%
- Industry: 25%
- Others: 10%
Why to attend?
3rd International Conference on Neuro-Oncology and Brain Tumor tends to bring together worldwide distinguished academics in the field of Neuro-oncologist, Oncologist, Radiation Oncologist, Medical Oncologists, Neuropharmacology, Neurology, Neuropediatricians, Pediatric Oncologists, Neurosurgeons, Neurophysiologists, Neuroscience Brain researchers, Public Health professionals, Scientists, Academic scientists, Industry researchers, Scholars to exchange about state of the art Research and Technologies and to bring discoveries of cancer to Patients. Attending International conference is for the Professional Development and to understand the current state of research and the challenges to future discovery.
The aim of the Conference is to provide a platform to academicians and practitioners from multiple disciplines to debate and deliberate on social change that is encompassed by innovation and technology.
For more details please visit : http://neurooncology.conferenceseries.com/
- Track 1:Neuro-Oncology
- Track 2:Brain Tumor
- Track 3:Neoplasms
- Track 4:Neurosurgery
- Track 5:Metastatic Cancer
- Track 6:Meningioma
- Track 7:Gangliocytoma
- Track 8:Choroid Plexus Tumor
- Track 9:Brainstem Glioma
- Track 10:Neuro Psychology and Psychiatry
- Track 11:Para Neoplastic Neurological Syndrome
- Track 12:Novel Therapies in Neuro-Oncology
- Track 13:Advancements in Neuro-Oncology
- Track 14:Advancements in Brain Tumor
- Track 15:Neuroradiology
- Track 16: NeuroImmunology
- Track 17:Neuroimaging
- Track 18:Medical Treatment of Metastatic Cancer to the Nervous System
- Track 19: Treatment of Cancer Related Complications
- Track 20:Neuro Pharmacology and Neuro Toxicology
- All accepted abstracts will be published in respective Supporting International Journals.
- Abstracts will be provided with Digital Object Identifier by Cross Ref.
See more at: https://neurooncology.conferenceseries.com/